264 related articles for article (PubMed ID: 10713673)
1. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
[TBL] [Abstract][Full Text] [Related]
2. Coupling of RAFTK/Pyk2 kinase with c-Abl and their role in the migration of breast cancer cells.
Zrihan-Licht S; Avraham S; Jiang S; Fu Y; Avraham HK
Int J Oncol; 2004 Jan; 24(1):153-9. PubMed ID: 14654952
[TBL] [Abstract][Full Text] [Related]
3. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio A; Di Domenico M; Castoria G; de Falco A; Bontempo P; Nola E; Auricchio F
EMBO J; 1996 Mar; 15(6):1292-300. PubMed ID: 8635462
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors.
Chang JH; Wilson LK; Moyers JS; Zhang K; Parsons SJ
Oncogene; 1993 Apr; 8(4):959-67. PubMed ID: 7681161
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
Sepp-Lorenzino L; Eberhard I; Ma Z; Cho C; Serve H; Liu F; Rosen N; Lupu R
Oncogene; 1996 Apr; 12(8):1679-87. PubMed ID: 8622888
[TBL] [Abstract][Full Text] [Related]
7. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
Tan M; Grijalva R; Yu D
Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
[TBL] [Abstract][Full Text] [Related]
8. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.
Pronk GJ; de Vries-Smits AM; Ellis C; Bos JL
Oncogene; 1993 Oct; 8(10):2773-80. PubMed ID: 8378086
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of components of the focal adhesion complex by heregulin: role of phosphatase SHP-2.
Vadlamudi RK; Adam L; Nguyen D; Santos M; Kumar R
J Cell Physiol; 2002 Feb; 190(2):189-99. PubMed ID: 11807823
[TBL] [Abstract][Full Text] [Related]
10. Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation.
Roof RW; Haskell MD; Dukes BD; Sherman N; Kinter M; Parsons SJ
Mol Cell Biol; 1998 Dec; 18(12):7052-63. PubMed ID: 9819392
[TBL] [Abstract][Full Text] [Related]
11. Regulation of extracellular signal-regulated kinase activity by p120 RasGAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation.
Koehler JA; Moran MF
Cell Growth Differ; 2001 Nov; 12(11):551-61. PubMed ID: 11714636
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
[TBL] [Abstract][Full Text] [Related]
14. Signaling transduction pathway of angiotensin II in human mesangial cells: mediation of focal adhesion and GTPase activating proteins.
Shikata Y; Shikata K; Matsuda M; Sugimoto H; Wada J; Makino H
Biochem Biophys Res Commun; 1999 Apr; 257(1):234-8. PubMed ID: 10092539
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone.
Shiota M; Tanihiro T; Nakagawa Y; Aoki N; Ishida N; Miyazaki K; Ullrich A; Miyazaki H
Mol Endocrinol; 2003 Apr; 17(4):534-49. PubMed ID: 12554790
[TBL] [Abstract][Full Text] [Related]
16. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
17. Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells.
Cheng JC; Frackelton AR; Bearer EL; Kumar PS; Kannan B; Santos-Moore A; Rifai A; Settleman J; Clark JW
Cell Growth Differ; 1995 Feb; 6(2):139-48. PubMed ID: 7756172
[TBL] [Abstract][Full Text] [Related]
18. Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins.
Gold MR; Crowley MT; Martin GA; McCormick F; DeFranco AL
J Immunol; 1993 Jan; 150(2):377-86. PubMed ID: 8419471
[TBL] [Abstract][Full Text] [Related]
19. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
20. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
Roovers K; Wagner S; Storbeck CJ; O'Reilly P; Lo V; Northey JJ; Chmielecki J; Muller WJ; Siegel PM; Sabourin LA
Oncogene; 2009 Aug; 28(31):2839-48. PubMed ID: 19525980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
